Connor, Clark & Lunn Investment Management Ltd.

Position in DXCM — Dexcom Inc

CIK 1596800 VANCOUVER, A1

Position in DXCM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$357,157

-$31,203 QoQ

Shares Held

5,303

+89.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#631

of 966 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. DXCM ranks #20 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	869,131	$78,864,946
2	BSX	Boston Scientific Corp	1,467,148	$62,617,875
3	PHG	Koninklijke Philips NV	563,724	$15,327,654
4	SNN	Smith & Nephew PLC	487,774	$14,052,767
5	NVCR	NovoCure Ltd	661,280	$10,018,391
6	IRTC	iRhythm Holdings, Inc.	42,314	$5,033,250
7	AXGN	Axogen, Inc.	67,118	$3,100,180
8	VREX	Varex Imaging Corp	293,435	$3,060,526

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$357,157	5,303	+89.4%	Shares	Sole	2026-08-13
2024-03-31	$388,360	2,800	-90.7%	Shares	Sole	2024-05-09
2022-09-30	$2,425,703	30,118	+59.2%	Shares	Sole	2022-11-10
2022-06-30	$1,409,585	18,913	+316.6%	Shares	Sole	2022-08-05
2022-03-31	$2,322,664	4,540	-42.0%	Shares	Sole	2022-05-12
2021-12-31	$4,206,466	7,834	+25.1%	Shares	Sole	2022-02-10
2021-09-30	$3,424,984	6,263	+43.4%	Shares	Sole	2021-11-12
2021-06-30	$1,864,709	4,367	-20.6%	Shares	Sole	2021-08-12
2021-03-31	$1,975,926	5,498	+4.8%	Shares	Sole	2021-05-13
2020-12-31	$1,939,551	5,246	+5.5%	Shares	Sole	2021-02-16
2020-09-30	$2,049,195	4,971	+13.3%	Shares	Sole	2020-11-12
2020-06-30	$1,778,895	4,388	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.